Skip to main navigation

- Silverback - Corp Menu

About
Science & Technology
Pipeline
Careers
- Open Positions
Contact
Investors

News Releases

- Silverback - Investor Relations

Home
News & Events
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Corporate Governance
Financials & Filings
- SEC Filings
- Quarterly Results
IR Resources
- Email Alerts
- Contact IR

Year

Silverback Therapeutics and ARS Pharmaceuticals Announce Merger

07-21-2022

Silverback Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

05-17-2022

Silverback Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

05-12-2022

Silverback Therapeutics Updates Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results

03-31-2022

Silverback Therapeutics to Present at the 42nd Annual Cowen Healthcare Conference

02-24-2022

Silverback Therapeutics to Participate in the SVB Leerink 11th Annual Global Healthcare Conference

02-03-2022

Silverback Therapeutics to Participate in the H.C. Wainwright Bioconnect Conference

01-05-2022

- Silverback - Investor Tools

Print Page
RSS Feeds
Email Alerts

- Silverback - Corp Menu

About
Science & Technology
Pipeline
Careers
- Open Positions
Contact
Investors

© Copyright 2022 - Silverback Therapeutics^®